Atorvastatin enhances bone density in ovariectomized rats given 17β-estradiol or human parathyroid hormone(1-34)

Endocrine

Volumn 24, Issue 2, 2004, Pages 121-129

  Kawane, Tetsuya ^a   Terashima, Shinichi ^a   Kurahashi, Izuru ^a   Yanagawa, Toru ^b   Yoshida, Hiroshi ^b   Horiuchi, Noboru ^a  

^a OHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Bone mineral density; Estrogen; Ovariectomized rats; Parathyroid hormone; Statins

Indexed keywords

ATORVASTATIN; ESTRADIOL; PARATHYROID HORMONE[1-34]; PROSTAGLANDIN E2; CALCIUM; HEPTANOIC ACID DERIVATIVE; PARATHYROID HORMONE; PARATHYROID HORMONE (1 34); PARATHYROID HORMONE (1-34); PEPTIDE FRAGMENT; PHOSPHORUS; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FEMUR CONDYLE; LOW DRUG DOSE; LUMBAR SPINE; METAPHYSIS; NONHUMAN; OSSIFICATION; OVARIECTOMY; PRIORITY JOURNAL; RAT; SHAM FEEDING; ANIMAL; BLOOD; FEMUR; HUMAN; LUMBAR VERTEBRA; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BONE DENSITY; CALCIUM; ESTRADIOL; FEMALE; FEMUR; HEPTANOIC ACIDS; HUMANS; INJECTIONS, SUBCUTANEOUS; LUMBAR VERTEBRAE; OVARIECTOMY; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PHOSPHORUS; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 16644398886     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:24:2:121     Document Type: Article

References (44)

1. Riggs, B. L. and Melton, L. J. III (1992). N. Engl. J. Med. 327, 620-627.
2. Christiansen, C. and Lindsay, R. (1990). Osteoporos. Int. 1, 7-13.
3. Conference Report (1993). Am. J. Med. 94, 646-650.
4. Margolis, R. N., Canalis, E., and Partridge, N. C. (1996). J. Clin. Endocrinol. Metab. 81, 872-877.
5. Neer, R. M., Arnaud, C. D., Zanchetta, J. R., et al. (2001). N. Engl. J. Med. 344, 1434-1441.
6. Kawane, T., Takahashi, S., Saitoh, H., Okamoto, H., Kubodera, N., and Horiuchi, N. (2002). Horm. Metab. Res. 34, 293-302.
7. Ma, Y. L., Bryant, H. U., Zeng, Q., et al. (2003). Endocrinology 144, 2008-2015.
8. g Goldstein, J. L. and Brown, M. S. (1990). Nature 343, 425-430.
9. Maron, D. J., Fazio, S., and Linton, M. F. (2000). Circulation 101, 207-213.
10. Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., and Bernini, F. (1999). Pharmacol. Ther. 84, 413-428.
11. Casey, P. J. and Seabra, M. C. (1996). J. Biol. Chem. 271, 5289-5292.
12. Mundy, G., Garrett, R., Harris, S., et al. (1999). Science 286, 1946-1949.
13. Maeda, T., Kawane, T., and Horiuchi, N. (2003). Endocrinology 144, 681-692.
14. Maeda, T., Matsunuma, A., Kawane, T., and Horiuchi, N. (2001). Biochem. Biophys. Res. Commun. 280, 874-877.
15. Fisher, J. E., Rogers, M. J., Halasy, J. M., et al. (1999). Proc. Natl. Acad. Sci. USA 96, 133-138.
16. van Beek, E., Lowik, C., van der Pluijm, G., and Papapoulos, S. (1999). J. Bone Miner. Res. 14, 722-729.
17. Wang, G. J., Chung, K. C., and Shen, W. J. (1995). J. Formos. Med. Assoc. 94, 589-592.
18. Maritz, F. J., Conradie, M. M., Hulley, P. A., Gopal, R., and Hough, S. (2001). Arterioscler. Thromb. Vasc. Biol. 21, 1636-1641.
19. Mundy, G. R., Chen, D., and Oyajobi, B. O. (2003) In: Primer on the metabolic bone diseases and disorders of mineral metabolism, fifth edition. Favus, M. J. (ed). The American Society for Bone Mineral Research: Washington, DC.
20. Kimmel, D. B., Bozzato, R. P., Kronis, K. A., et al. (1993) Endocrinology. 132, 1577-1584.
21. Turner, R. T., Vandersteenhoven, J. J., and Bell, N. H. (1987) J. Bone Miner. Res. 2, 115-122.
22. Maeda, T., Matsunuma, A., Kurahashi, I., Yanagawa, T., Yoshida, H., and Horiuchi, N. (2004) J. Cell Biochem. 92, 458-471.
23. Staal, A., Frith, J. C., French, M. H., et al. (2003). J. Bone Miner. Res. 18, 88-96.
24. Skoglund, B., Forslund, C., and Aspenberg, P. (2002). J. Bone Miner. Res. 17, 2004-2008.
25. Meier, C. R., Schlienger, R. G., Kraenzlin, M. E., Schlegel, B., and Jick, H. (2000). JAMA 283, 3205-3210.
26. Wang, P. S., Solomon, D. H., Mogun, H., and Avorn, J. (2000). JAMA. 283, 3211-3216.
27. Chung, Y. S., Lee, M. D., Lee, S. K., Kim, H. M., and Fitzpatrick, L. A. (2000). J. Clin .Endocrinol. Metab. 85, 1137-1142.
28. Edwards, C. J., Hart, D. J., and Spector, T. D. (2000). Lancet 355, 2218-2219.
29. Rejnmark, L., Buus, N. H., Vestergaard, P., Andreasen, F., Larsen, M. L., and Mosekilde, L. (2002). Eur. J.Clin. Invest. 32, 581-589.
30. Sirola, J., Honkanen, R., Kroger, H., Jurvelin, J. S., Maenpaa, P., and Saarikoski, S. (2002). Osteoporos. Int. 13, 537-541.
31. Illingworth, D. R. and Tobert, J. A. (1994). Clin. Ther. 16, 366-385.
32. Sato, M., Vahle, J., Schmidt, A., et al. (2002). Endocrinology 143, 3230-3242.
33. Thompson, D. D., Simmons, H. A., Pirie, C. M., and Ke, H. Z. (1995). Bone 17(Suppl.), 125S-133S.
34. Kalu, D. N., Arjmandi, B. H., Liu, C. C., Salih, M. A., and Birnbaum, R. S. (1994). Bone Miner. 25, 135-148.
35. Black, A. E., Hayes, R. N., Roth, B. D., Woo, P. and Woolf, T. F. (1999). Drug Metab. Dipos. 27, 916-923.
36. Shiraishi, A., Takeda, S., Masaki, T., et al. (2000). J. Bone Miner. Res. 15, 770-779.
37. Kalu, D. N., Liu, C.-C., Hardin, R. R., and Hollis, B. W. (1989). Endocrinology. 124, 7-16.
38. Colin, E. M., Van Den Bemd, G. J., Van Aken, M., et al. (1999). J. Bone Miner. Res. 14, 57-64.
39. Kalu, D. N. and Chen, C. (1999). J. Bone Miner. Res. 14, 593-601.
40. Rejnmark, L., Buus, N. H., Vestergaard, P., et al. (2004). J. Bone Miner. Res. 19, 737-744.
41. LaCroix, A. Z., Cauley, J. A., Pettinger, M., et al. (2003). Ann. Intern. Med. 139, 97-104.
42. Montagnani, A., Gonnelli, S., Cepollaro, C., et al. (2003). Bone 32, 427-433.
43. Corsini, A., Raiteri, M., Soma, M. R., Bernini, F., Fumagalli, R., and Paoletti, R. (1995). Am. J. Cardiol. 13, 21A-28A.
44. Kureishi, Y., Luo, Z., Shiojima, I., et al. (2000). Nat. Med. 6, 1004-1010.